<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Onward-Medical on Bioecon</title><link>https://en.bioecon.ru/companies/onward-medical/</link><description>Recent content in Onward-Medical on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 21:31:49 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/onward-medical/index.xml" rel="self" type="application/rss+xml"/><item><title>Bioelectronic medicine &amp; neuromodulation</title><link>https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/</guid><description>Electroceutical devices that treat disease by electrically stimulating nerves rather than with drugs — vagus and splenic nerve neuroimmune modulation, AI-personalized spinal cord stimulation, hypoglossal nerve stimulation and implantable neuromodulation for paralysis and neurological disease: SetPoint Medical, Nevro Corp and Inspire Medical Systems in the US, Galvani Bioelectronics and Onward Medical in Europe, and PINS Medical in China.</description></item></channel></rss>